Pharm'Up 
The Central Drugs Standard Control Organization (CDSCO) has announced a significant update to its regulatory workflow, aimed at accelerating the approval process for importing or manufacturing new drugs in India. Starting June 1, 2026, the regulator will implement a faster system for issuing No Objection Certificates (NOCs) required for mandatory drug testing.
Key Changes to the NOC Process
Under the current framework, the CDSCO conducts a detailed examination of product specifications before issuing an NOC for testing. The new directive transforms this into a near-instantaneous process:
- Immediate Issuance: NOCs for testing drug samples will now be issued immediately upon receipt of the application by the concerned division.
- Basis of Approval: This fast-track issuance will be based on prevailing Pharmacopoeia standards and Product Specific Quality Management Systems (QMS).
- Applicant Requirements: Companies must submit finalized regulatory specifications at the time of filing, ensuring they align with the Drugs and Cosmetics Act, 1940.
Designated Testing Laboratories
Before final approval is granted, drug samples must undergo rigorous testing at specialized national laboratories to verify their quality and safety:
- Indian Pharmacopoeia Commission, Ghaziabad.
- Central Drugs Testing Laboratory, Mumbai.
- Central Drugs Laboratory, Himachal Pradesh.
- National Institute of Biologicals, Noida.
Broader Regulatory Reforms in 2026
This move follows earlier reforms in 2026 to the New Drugs and Clinical Trials Rules, 2019, which were designed to foster pharmaceutical innovation:
- Reduced Timelines: Regulatory approval windows have been slashed from 90 working days to 45 working days.
- Simplified Licensing: Certain manufacturers can now begin limited production for analytical and non-clinical testing simply by submitting a prior intimation.
Summary of the New System
| Feature | Old System | New System (Effective June 1, 2026) |
| NOC Issuance | Post-examination of specifications | Immediate upon application |
| Documentation | Specification review during process | Finalized specifications required at filing |
| Goal | Regulatory oversight | Speeding up development & reducing bureaucracy |
About the Author
